NS Healthcare is using cookies
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
White Paper
November 9, 2016
Vitamin K2 MK-7 is poised for widespread consumer uptake in the immediate future due to its superior bone and heart health benefits. Kappa Bioscience has the vision to deliver vitamin K2 to the mass market, making it accessible for everybody, everywhere. Positioned for unlimited-scale market opportunities, the company offers customers a strong partner in the development of new market growth with K2VITAL.
Download to find out more.